WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY) Short Interest Down 58.1% in June

WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY) saw a large decline in short interest in the month of June. As of June 15th, there was short interest totaling 65,100 shares, a decline of 58.1% from the May 31st total of 155,338 shares. Based on an average daily volume of 127,819 shares, the short-interest ratio is presently 0.5 days. Approximately 0.0% of the company’s shares are sold short.

WuXi Biologics (Cayman) Price Performance

Shares of WuXi Biologics (Cayman) stock opened at $8.60 on Monday. WuXi Biologics has a 12-month low of $6.20 and a 12-month high of $11.21. The company’s fifty day simple moving average is $8.36 and its two-hundred day simple moving average is $8.92.

WuXi Biologics (Cayman) Company Profile

WuXi Biologics (Cayman) Inc, trading OTC as WXXWY, is a global contract research, development and manufacturing organization (CDMO) specializing in biologics. Founded as a spin-out from WuXi AppTec and incorporated in the Cayman Islands in 2017, the company offers end-to-end support across the biologics value chain. Its service portfolio encompasses discovery biology, analytical development, process chemistry and large-scale manufacturing for therapeutic proteins and antibodies.

The firm’s core offerings include the development of monoclonal antibodies, recombinant proteins and cell and gene therapy vectors.